Effects of a Novel Dexamethasone Hydrogel Drug Delivery System on Cytokine and Mucin Expression in a Three-Dimensional In Vitro Conjunctival Inflammation Model
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.1.42 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Julian Schwebler and 7 co-authors. Institution: Department for Functional Materials in Medicine and Dentistry, University Hospital Würzburg, Würzburg, Bavaria, Germany. Major MEDLINE topics: Dexamethasone, Cytokines, Mucins, Conjunctiva. Cited 3 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Purpose
Inflammation of the ocular surface is one of the key symptoms in dry eye disease (DED). Various eye drops are available to alleviate conjunctival inflammation but have limited effect and poor patient compliance. To facilitate testing of new treatments, we established a three-dimensional (3D) in vitro conjunctival inflammation model and tested a novel dexamethasone (Dex) hydrogel drug-delivery system on cytokine and mucin expression.
Methods
Primary human conjunctival fibroblasts were embedded in a compressed collagen matrix. Primary epithelial cells were seeded on top and cultured at the air-liquid-interface for 15 days. Inflammation was induced via TNF-α, IL-1β, or their combination. Pristine Dex, poly(2-oxazoline) (POx)-based Dex micelles and modified acrylic acid based hydrogel loaded with Dex micelles were applied to the inflammation model to verify the therapeutic efficacy. Pro-inflammatory cytokines were analyzed via real-time quantitative PCR (RT-qPCR) and ELISA. Conjunctival mucins were analyzed via RT-qPCR.
Results
The expression of all tested cytokines (IL1A, IL1B, IL6, IL8, MMP9) was significantly increased after combined stimulation with TNF-α and IL-1β. Treatment with Dex-formulations significantly reduced IL6 expression. The expression of mucins was significantly increased after stimulation and was further elevated after treatment with Dex-formulations.
Conclusions
We established an inflammation model, in which the effects of novel treatment options on cytokine and mucin expression can be analyzed. This opens a new in vitro test platform for DED medication and enables deeper investigations into conjunctival mucin expression in inflamed tissue.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department for Functional Materials in Medicine and Dentistry, University Hospital Würzburg, Würzburg, Bavaria, Germany.
- Translational Center Regenerative Therapies (TLC-RT), Fraunhofer Institute for Silicate Research (ISC), Würzburg, Bavaria, Germany.
- Department of Ophthalmology, University Hospital Würzburg, Würzburg, Bavaria, Germany.
Cite
APA
Schwebler, J., Verma-Fuehring, R., Kalantari, N., Berger, C., Kampik, D., Hillenkamp, J., Haider, M. S., & Lotz, C. (2026). Effects of a Novel Dexamethasone Hydrogel Drug Delivery System on Cytokine and Mucin Expression in a Three-Dimensional In Vitro Conjunctival Inflammation Model. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.1.42
Vancouver
Schwebler J, Verma-Fuehring R, Kalantari N, Berger C, Kampik D, Hillenkamp J, et al. Effects of a Novel Dexamethasone Hydrogel Drug Delivery System on Cytokine and Mucin Expression in a Three-Dimensional In Vitro Conjunctival Inflammation Model. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.1.42
BibTeX
@article{Schwebler2026,
author = {Schwebler, Julian and Verma-Fuehring, Raoul and Kalantari, Niloofar and Berger, Constantin and Kampik, Daniel and Hillenkamp, Jost and Haider, Malik Salman and Lotz, Christian},
title = {Effects of a Novel Dexamethasone Hydrogel Drug Delivery System on Cytokine and Mucin Expression in a Three-Dimensional In Vitro Conjunctival Inflammation Model},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.1.42}
}
EUVIMED